Corey Michael Watton is Director at ZEVRA THERAPEUTICS, INC. (ZVRA). They have made 6 open-market trades across 1 company since 2023, most recently 2026-08-10.
CIK 0001975404
5 open-market purchases totalling $12K since 2023, against 1 sale. Across 5 scored buys the stock is down 0.4% at ninety days, and 4.5 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| ZVRA | 1,800 | $18K |
Shares reported on the most recent Form 4, priced at the 2026-08-12 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 20% | 40% | 40% |
| Avg Move | -5.7% | -5.3% | -0.4% |
| Alpha | -5.1% | -8.0% | -4.5% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ZVRA | SELL | 2026-08-10 | 2026-08-12 | $11.25 | $138K | +1.6% | +4.5% | — |
| ZVRA | BUY | 2025-03-28 | 2025-03-31 | $7.84 | $2K | -14.0% | -3.9% | +15.5% |
| ZVRA | BUY | 2024-10-11 | 2024-10-16 | $7.92 | $4K | -5.8% | +0.8% | -9.9% |
| ZVRA | BUY | 2023-06-23 | 2023-06-26 | $5.95 | $2K | -3.0% | -6.2% | -4.6% |
| ZVRA | BUY | 2023-06-09 | 2023-06-13 | $5.52 | $2K | -15.5% | -17.7% | -7.8% |
| ZVRA | BUY | 2023-05-30 | 2023-05-31 | $5.11 | $2K | +9.9% | +0.6% | +4.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.